Showing results (1151-1160 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|February 4, 2021
Oral Levodopa Formulation Does Not Affect Progression of Parkinson DiseaseAmbica Sethi, Sonam Dilwali, Morgan McCreary, et al.Clinical Neuropharmacology|April 1, 1987
Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesisM Harris, L Nora, C M TannerClinical Neuropharmacology|August 1, 1987
Exercise and the antiparkinsonian response to levodopaM M Mouradian, J L Juncos, C Serrati, et al.Clinical Neuropharmacology|August 1, 1987
Paroxysmal dystonia responsive to anticholinergic drugsF Micheli, M Fernandez Pardal, R de Arbelaiz, et al.Clinical Neuropharmacology|October 1, 1987
Persistent upregulation of brain adenosine receptors in response to chronic carbamazepine treatmentP J Marangos, P Montgomery, S R Weiss, et al.Clinical Neuropharmacology|January 1, 1990
Are biochemical markers for treatment-resistant schizophrenia state dependent or traits?D P van Kammen, N SchoolerClinical Neuropharmacology|January 14, 2012
Gabapentin as add-on treatment for somatoform disorder: a case reportRiccardo Guglielmo, Giovanni Martinotti, Luigi JaniriClinical Neuropharmacology|July 9, 2011
Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomasJana Martinkova, Ludmila Trejbalova, Michaela Sasikova, et al.Clinical Neuropharmacology|July 9, 2011
Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trialSeyed Ehsan Mohammadianinejad, Vahid Abbasi, Seyed Aidin Sajedi, et al.Clinical Neuropharmacology|July 9, 2011
The dubious effect of milnacipran for the treatment of burning mouth syndromeKoreaki SugimotoPageof 236